Skip to content

NOVEL MANAGEMENT OF DEPRESSION USING KETAMINE IN THE INTENSIVE CARE UNIT

Nirmaljot Kaur, Siva Naga S. Yarrarapu, Abhishek R. Giri, Kathleen A. Rottman Pietrzak, Christan Santos, Philip E. Lowman, Shehzad Niaz, Pablo Moreno Franco, Devang K. Sanghavi

medRxiv Preprint Server September 23, 2021 preprint DOI: 10.1101/2021.09.23.21262316 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case study Case report
Intervention Ketamine
Topics Depression Esketamine Ketamine
Keywords Ketamine depression treatment Intensive care psychiatry Rapid antidepressant effect Novel therapies
Key findings Ketamine can be effectively used for depression management in the intensive care unit.

Abstract

Background Ketamine, a dissociative anesthetic, induces remission of depression by antagonizing glutaminergic NMDA receptors. Ketamine has been used previously in outpatient setting for treatment-resistant depression, but we showcase its utility in depression management at the Intensive Care Unit (ICU).